Clinical Trial Update: Anti-viral Therapy in Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial of an antiviral therapy in Alzheimer's disease with herpes simplex virus co-infection has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Herpes Simplex Virus Type Infection

Snippet

Sponsor: Columbia University | Conditions: Alzheimer Disease, Herpes Simplex 1 | Phase 2 | Status: COMPLETED | Results posted: 2025-09-08